Syringocystadenocarcinoma papilliferum: a rare tumor with a favorable prognosis.

Syringocystadenocarcinoma papilliferum: a rare tumor with a favorable prognosis. Dermatol Online J. 2013;19(9):19620 Authors: Peterson J, Tefft K, Blackmon J, Rajpara A, Fraga G Abstract Syringocystadenocarcinoma papilliferum (SCACP) is a rare adenexal carcinoma with only 21 cases reported in the literature. Most patients describe a long-standing mass with recent change, supporting the idea that SCACP arises from malignant transformation of pre-existing syringocystadenoma papilliferum (SCAP). Syringocystadenocarcinoma papilliferum is generally treated with wide surgical excision of the lesion and patients do exceeding well and require no systemic therapy. PMID: 24050294 [PubMed - in process]
Source: Dermatol Online J - Category: Dermatology Authors: Tags: Dermatol Online J Source Type: research